Body Weight Changes, Breast Neoplasms
Conditions
Keywords
Breast Cancer
Brief summary
Twenty-five women will be followed through their breast cancer treatment. The women will be asked to provide their opinions and desires for lifestyle intervention at different times throughout treatment. In addition, basic clinical data will be collected . The primary goal of this pilot study is to investigate the physical and behavioral changes that occur in patients receiving treatment for breast cancer.
Detailed description
In this cross sectional, longitudinal, observational study, 25 women will be followed through their treatment for stage I-III breast cancer. The women will be asked to provide their opinions and desires for lifestyle intervention at four timepoints throughout treatment. In addition to qualitative data, basic clinical data will be collected (anthropometrics, vital signs, dietary intake, and physical activity). The primary goal of this pilot study is to investigate the anthropometric and behavioral changes that occur in patients undergoing adjuvant chemotherapy for breast cancer. Aim 1: To better understand patients' attitudes toward and perceived barriers to nutrition and physical activity interventions during neoplastic treatment. Hypothesis: Patients' reported attitudes, motivation, and perceived barriers will change throughout treatment. Aim 2: To measure the physical and metabolic changes that occur throughout neoplastic treatment for breast cancer. Hypothesis: Over 50% of the participants will gain body weight during treatment and metabolic parameters will trend with body weight change.
Interventions
None listed
Sponsors
Pennington Biomedical Research Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Female * ≥18 years of age * Diagnosed with stage I, II or III breast cancer with plans to undergo endocrine and/or chemotherapy treatment (radiation in combination with one or more of these therapies is acceptable) * Willing to complete up to 4 clinic visits
Exclusion criteria
* Have received neoadjuvant therapy for current diagnosis * Currently receiving adjuvant chemotherapy or other adjuvant therapy that was initiated prior to study enrollment * History of cancer and neoplastic treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Perceived attitudes towards lifestyle interventions | 9 months | Qualitative data collected via semi-structured interview |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Diet | 9 months | 24 hour recall (ASA24) to assess food intake changes throughout treatment |
| Physical Activity | 9 months | Wrist worn Actigraph accelerometer to assess activity changes throughout treatment |
| Body Weight | 9 months | Body weight change throughout treatment |
Countries
United States
Outcome results
None listed